Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

59.10
Delayed Data
As of Sep 27
 -0.56 / -0.94%
Today’s Change
8.00
Today|||52-Week Range
61.60
+53.19%
Year-to-Date
3 Stocks to Avoid in Healthcare
8:05am / MotleyFool.com - Paid Partner Content
I Am One of the Underinvested Bulls Right Now
Sep 22 / TheStreet.com - Paid Partner Content
There's No Debate, Dip Buyers Are Jittery
Sep 26 / TheStreet.com - Paid Partner Content
Stock Futures Rise as Wall Street Finds Relief in a Patient Fed
Sep 22 / TheStreet.com - Paid Partner Content
The Woman Behind Sarepta Therapeutics' Success
Sep 24 / MotleyFool.com - Paid Partner Content
Sarepta (SRPT) Stock Slides in After-Hours Trading on Public Offering
Sep 21 / TheStreet.com - Paid Partner Content
2 Stocks I'd Never Buy, and 1 I'll Consider
Sep 23 / MotleyFool.com - Paid Partner Content
Sarepta (SRPT) Stock Lower, BioMarin to Appeal Patent Ruling
Sep 21 / TheStreet.com - Paid Partner Content
5 Stocks With Amazon-Like Growth Potential
Sep 22 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD ...
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close59.66
Today’s open59.05
Day’s range57.71 - 59.94
Volume3,128,041
Average volume (3 months)4,776,745
Market cap$3.1B
Dividend yield--
Data as of 09/27/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book14.17

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-1.15-0.91%
GLPGGalapagos NV+1.66+2.49%
CBPOChina Biologic Produ...+1.21+1.00%
CTLTCatalent Inc+0.16+0.61%
Data as of 09/27/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs